Human T Lymphotropic Virus Type I (HTLV-I)-AssociatedMyelopathy/Tropical Spastic Paraparesis (HAM/TSP). Recent Perspectives.

  • IJICHI Shinji
    the Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University
  • OSAME Mitsuhiro
    the Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University

この論文をさがす

抄録

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a well-defined clinicopathological entity, and approximately 1, 900 patients with HAM/TSP have been reported in the world. Improved polymerase chain reaction (PCR)-based in situ techniques have allowed a better appreciation of the cellular localization of the virus activation in infected patients, and there is accumulating evidence that HAM/TSP is characterized by a distributional bias of viral activation between the blood flow and central nervous system (CNS). This review summarizes the current status of our understanding of HAM/TSP, and emphasizes the possible pathogenic involvement of cellular interactions between infected cells and responding immunocompetent cells in the CNS of patients with HAM/TSP. In addition, the notable systemic manifestations with or without myelopathy in HTLV-I-infected individuals are described.<br>(Internal Medicine 34: 713-721, 1995)

収録刊行物

  • Internal Medicine

    Internal Medicine 34 (8), 713-721, 1995

    一般社団法人 日本内科学会

被引用文献 (6)*注記

もっと見る

参考文献 (126)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ